Wednesday, June 10, 2015 8:03:16 AM
Milestone Scientific’s Epidural & IA Subsidiary and Moss S.p.A. Sign Exclusive Distribution Agreement for Epidural Instrument in Italy
Announces Plans to Broaden U.S. Distribution Strategy
LIVINGSTON, NJ, June 10, 2015 -- Milestone Scientific Inc. (NYSE MKT: MLSS), a medical R&D company that designs, patents, incubates and commercializes a growing portfolio of innovative injection technologies, today announced that its Epidural & Intra-Articular (IA) Subsidiary has entered into an exclusive distribution agreement with Moss S.p.A. for distribution of the epidural instrument in Italy. Moss is one of the leading distributors of diagnostic and specialty surgery equipment in Italy.
The term of the agreement between Milestone Scientific’s Epidural & IA subsidiary and MOSS S.p.A. is three years and includes annual minimum purchases of epidural instruments and disposable kits. Milestone will provide sales literature, organize training classes and provide product, while Moss S.p.A. will be responsible for sales and marketing support, including advertising, product placement in catalogs, product displays and trade exhibits. MOSS has also committed to hiring 15 sales representatives dedicated to the sale of the epidural instrument within the first year.
Leonard Osser, Chief Executive Officer of Milestone Scientific commented, “Italy is a viable market for our epidural instrument with over 1 million epidurals administered for surgery per year and over 60,000 epidurals administered for childbirth. Since its founding in 2000, Moss has demonstrated its ability to assess market needs and to successfully address those needs with innovative products in the medical arena. Moss’ extensive distribution capabilities in Italy will benefit Milestone and we are pleased to have them as our exclusive distribution partner in the region.”
The Epidural & IA Subsidiary also announced plans to broaden its U.S. distribution strategy beyond the current focus on labor and delivery markets.
Mr. Osser continued, “While our prior distribution partner in the U.S. maintains a solid network within birthing centers across the U.S., we’ve decided after discussion with other distributors in the pain management sector that an exclusive arrangement in this arena was too limiting given the overlap between anesthesiologists in private clinics and hospitals. These practitioners have the ability to use our instrument for both labor and delivery, as well as other pain management applications. In the U.S. alone, there are 8.9 million annual procedures that fall outside of the labor and delivery segment, many in private pain management clinics. As a result, the company believes a build out of a network of regional distribution partners whose strengths include hospitals, clinics and pain management centers will give us far greater penetration in the broader U.S. market. We look forward to announcing these partnerships in the coming months and believe that this strategy will result in greater market penetration within the respective regions. At the same time, our U.S. trials are moving forward and we look forward to announcing additional milestones in the near future.”
Recent MLSS News
- Milestone Scientific Schedules First Quarter 2024 Financial Results and Business Update Conference Call • GlobeNewswire Inc. • 05/13/2024 12:30:00 PM
- Milestone Scientific Commences Sales of CompuFlo® Epidural Disposables within PRC Alliance Pain Relief Center in Ormond Beach, Florida • GlobeNewswire Inc. • 04/03/2024 12:30:00 PM
- Milestone Scientific Achieves 12% Increase in Revenue and 39% Increase in Gross Profit for the Year Ended 2023 • GlobeNewswire Inc. • 04/01/2024 11:00:00 AM
- Milestone Scientific Schedules 2023 Year-End Financial Results and Business Update Conference Call • GlobeNewswire Inc. • 03/28/2024 03:45:00 PM
- Milestone Scientific Commences Sales of CompuFlo® Epidural Disposables within Omaha Pain Physicians • GlobeNewswire Inc. • 03/14/2024 12:30:00 PM
- Milestone Scientific Commences Direct Sales of STA Single Tooth Anesthesia System® with Meridian Endo & Perio • GlobeNewswire Inc. • 02/28/2024 01:30:00 PM
- Milestone Scientific Commences Direct Sales of STA Single Tooth Anesthesia System® to Maine Dental Group, a Premier Group Practice with 21 Locations Across the Northeast • GlobeNewswire Inc. • 02/20/2024 01:30:00 PM
- Milestone Scientific CEO Provides Letter to Shareholders; Provides Positive Reimbursement Update • GlobeNewswire Inc. • 01/16/2024 01:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/12/2024 09:34:33 PM
- Milestone Scientific Inc. Announces Closing of $3.0 Million Public Offering of Common Stock • GlobeNewswire Inc. • 12/13/2023 10:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/13/2023 05:01:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/12/2023 10:21:29 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 12/12/2023 10:10:53 PM
- Milestone Scientific Inc. Announces Pricing of $3.0 Million Public Offering of Common Stock • GlobeNewswire Inc. • 12/11/2023 01:33:45 AM
- Milestone Scientific Inc. Announces Proposed Public Offering of Common Stock • GlobeNewswire Inc. • 12/08/2023 09:03:25 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 12/08/2023 09:00:28 PM
- Milestone Scientific Commences Sales of CompuFlo® Disposables for Use in Neurostimulation Spinal Cord Implantation Procedures • GlobeNewswire Inc. • 12/08/2023 01:30:00 PM
- Milestone Announces Agreement with Bioline Supply to Distribute the CompuFlo® Epidural System and Related Disposables Across Spain • GlobeNewswire Inc. • 11/28/2023 01:30:00 PM
- Milestone Scientific Achieves Revenue of $2.1 Million and Provides Business Update for the Third Quarter of 2023 • GlobeNewswire Inc. • 11/15/2023 12:00:00 PM
- Milestone Scientific Schedules Third Quarter 2023 Financial Results and Business Update Conference Call • GlobeNewswire Inc. • 11/10/2023 01:30:00 PM
- Milestone Scientific Commences Sales of CompuFlo® Epidural Disposables within Island Ambulatory Surgery Center in Brooklyn, New York • GlobeNewswire Inc. • 11/09/2023 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 10/31/2023 04:15:17 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/23/2023 09:40:04 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/19/2023 09:39:33 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 10/19/2023 06:36:15 PM
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM